Results 201 to 210 of about 552,750 (375)
Association between lipid-lowering drug targets and the risk of cystic kidney disease: a drug-target Mendelian randomization analysis. [PDF]
Lian Z, Liang Z, Chen Q, Xie C, Kong Y.
europepmc +1 more source
Costs and Benefits of Prenatal Screening For Cystic Fibrosis [PDF]
Newly-developed genetic tests based on restriction fragment length polymorphisms (RFLPs) promise to facilitate the early detection of genetic diseases. Several such tests are now available for the prenatal detection of cystic fibrosis (CF), a common and ...
Alan M. Garber, Joseph P. Fenerty
core
We conducted a Phase I trial of CBA‐1205, a novel monoclonal antibody targeting DLK1, in advanced solid tumors, demonstrating safety and tolerability with no dose‐limiting toxicities. Preliminary efficacy was observed, with six patients achieving stable disease for over 6 months, and sDLK1 was identified as a potential biomarker associated with ...
Yuki Katsuya+12 more
wiley +1 more source
The spectrum of diseases, genetic landscape and new mutation sites of hereditary cystic kidney disease. [PDF]
Bi J+6 more
europepmc +1 more source
A Rare Diagnosis of Caroli Syndrome in a Young Patient [PDF]
ABSTRACT Caroli syndrome is a rare but serious congenital disorder associated with portal hypertension and polycystic kidney disease. Early diagnosis via imaging, particularly MRCP, is crucial to prevent life‐threatening complications such as cholangitis and biliary cirrhosis.
Karimzadeh‐Soureshjani E+4 more
europepmc +2 more sources
Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women
ABSTRACT Context Androgen excess is common in women and refers to clinical or biochemical evidence of elevated androgenic steroids such as testosterone. It is associated with underlying polycystic ovary syndrome in the majority of cases. However severe androgen excess is less common and may indicate the presence of underlying adrenal or ovarian ...
Yasir S. Elhassan+14 more
wiley +1 more source
Imaging Diagnosis-Sonographic Features of Bilateral Renal Lymphangiectasia in an Azotemic Dog. [PDF]
Wang Y+4 more
europepmc +1 more source
Abstract Objective Fingolimod is the first oral sphingosine‐1‐phosphate receptor modulator approved in Japan for multiple sclerosis (MS). A large Japanese observational study of fingolimod in patients with MS was carried out to support its safety and effectiveness in a real‐world setting.
Noriko Sato+7 more
wiley +1 more source
Extrarenal Clinical Features are Reported for Most Genes Implicated in Genetic Kidney Disease. [PDF]
Serrano B, Savige J.
europepmc +1 more source